Introduction: Systematic lymph node dissection (SND) is the standard procedure in surgical treatment for NSCLC, but the value of this approach for survival and nodal staging is still uncertain. In this study, we evaluated the potential of lobe-specific lymph node dissection (L-SND) in surgery for NSCLC by using a propensity score matching method.
Introduction
Surgery is the main treatment for early-stage NSCLC 1 using a standard procedure of lobectomy or pneumonectomy with systematic lymph node dissection (SND). 2, 3 However, the influence of lymph node dissection on postoperative survival is uncertain and the optimal extent of lymph node dissection for accurate staging of NSCLC is also unclear, even though SND is recommended for accurate histological staging of lymph node spread. 4, 5 The location of the primary tumor is thought to influence the pattern of lymph node metastasis. Okada et al. described the skip N2 metastasis pattern in 1998. 6 Subsequently, Asamura et al. described characteristic mediastinal nodal metastasis patterns on the basis of primary tumor location, 7 with tumors in the right upper lobe and left upper segment tending to metastasize to *Corresponding author.
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the superior mediastinal lymph node station, whereas single-station metastasis to the subcarinal node is very rare and tumors in the lower lobe on both sides show metastases to the subcarinal node and to the superior mediastinal or aortic node. Asamura et al. suggested that subcarinal node metastasis was the touchstone of mediastinal spread of lower lobe tumors because singlenode or single-station metastases were more frequent in the subcarinal station, and the prognosis of lower lobe tumors with subcarinal and superior mediastinal lymph node metastases was extremely poor even if SND was performed. On the basis of these findings, Okada et al. showed the efficacy of selective mediastinal lymphadenectomy performed according to the primary tumor site in clinical stage I NSCLC. 8 These results have prompted frequent performance of lobe-specific lymph node dissection (L-SND) in elderly patients or patients with no apparent nodal metastases preoperatively. However, it is unclear whether L-SND is equal to SND in terms of postoperative outcome and accurate nodal staging, in part because retrospective comparisons of L-SND and SND might be biased by confounding factors in patient selection because elderly patients, patients in an earlier stage, and those with a poor physical status tend to receive L-SND. In this study, we evaluated the potential of L-SND in surgical treatment of NSCLC with use of the propensity score (PS) matching method to eliminate selection biases as much as possible.
Materials and Methods

Patients
A total of 981 consecutive patients with NSCLC who underwent pulmonary resection at 10 hospitals affiliated with Yokohama City University from January 2005 through December 2007 were evaluated. Among these patients, 808 underwent surgery for cT1a-2b N0-1 M0 disease without receiving induction chemotherapy or radiotherapy. After exclusion of 14 patients with pneumonectomy, 165 with sublobar resection, and 64 with right middle lobectomy or bilobectomy, a total of 565 patients who underwent lobectomy with lymph node dissection for cT1a-2b N0-1 M0 NSCLC were enrolled in the study. Exclusion of cases with right middle lobectomy was based on the findings of Asamura et al. 7 and Watanabe et al. 9 , which showed no specific lymphatic spread pattern for right middle lobe tumors. Clinical T, N, and M stage were diagnosed according to the seventh edition of the TNM staging system for lung cancer issued by the International Union Against Cancer. 10 Clinical N1 stage was defined as having lymph nodes with a shortaxis diameter larger than 1 cm on computed tomography (CT) or fludeoxyglucose F 18 uptake greater than that of surrounding normal structures on positron emission tomography (PET) in stations 10, 11, 12, and 13. cN2 disease was diagnosed in patients with mediastinal lymph nodes with a short-axis diameter larger than 1 cm on CT or fludeoxyglucose F 18 uptake greater than that of surrounding normal structures on PET, and those patients were excluded from the study. Preoperative mediastinal nodal biopsy was not mandatory. Postoperative follow-up examinations were performed every 3 to 6 months at each hospital for at least 5 years after resection.
Definition of Lymph Node Dissection
Because the study was retrospective, we first defined lymph node dissection on the basis of postoperative pathological nodal status to ensure the study's quality. The nodal dissection criteria included (1) resection of at least three lymph nodes or three stations from hilar and intrapulmonary nodes, (2) resection of at least three lymph nodes or three stations from mediastinal nodes, and (3) resection of at least six lymph nodes or six stations in total. These criteria were taken from a recommendation for accurate pathological nodal staging made by The Japan Lung Cancer Society.
11
Patients who underwent nodal dissection and met all these criteria according to pathological evaluation were defined as those who truly underwent nodal dissection and then classified into two groups on the basis of dissected lymph nodal area. Patients with dissection of all ipsilateral mediastinal lymph nodes (stations 2R, 4R, 7, 8, and 9 for right-side tumors and stations 4L, 5, 6, 7, 8, and 9 for left-side tumors) and hilar lymph nodes were placed in the SND group, and those with dissection of hilar lymph nodes and specific mediastinal lymph node stations depending on the lobar location of the primary tumor (stations 2R and 4R for right upper lobe tumors, stations 4L, 5L, and 6L for left upper lobe tumors; and stations 7, 8, and 9 for lower lobe tumors of both sides) formed the L-SND group. The lymph node station maps were obtained from the International Association for the Study of Lung Cancer lymph node map. 12 Patients who underwent lymph node dissection but did not meet all criteria according to pathological evaluation were classified as cases with uncertain dissection and included in the nodal sampling (NS) group.
Statistical Analysis
After receiving approval from the institutional review boards of the participating hospitals, we retrospectively reviewed the medical records of each patient and recorded the following clinicopathological variables: age, sex, smoking history, presence of chronic obstructive pulmonary disease, preoperative PET scan, preoperative serum carcinoembryonic antigen level, lobar location of the primary tumor, operative approach, operative time, intraoperative blood loss, maximum tumor diameter, cT, cN, pT, pN, number of resected lymph nodes, postoperative histological examination results, major postoperative complications (chylothorax, bronchopleural fistula, and acute empyema), and adjuvant chemotherapy. All pathological evaluations were conducted by pathologists in each hospital. Overall survival (OS) was defined as the period between the date of surgical resection and that of death from any cause.
The PS matching method was used to reduce bias, which acts as a confounding factor. The PS was calculated using logistic regression based on 10 preoperative factors (age, sex, smoking history, presence of chronic obstructive pulmonary disease, preoperative PET scan, maximum tumor size, cT, cN, lobar location of the primary tumor, and operative approach) that were thought to be potentially associated with selection of the extent of lymph node dissection. Patients in the SND and L-SND groups were matched in a 1:1 ratio according to their PS by using the Greedy algorithm.
Clinicopathological variables were compared between groups by Kruskal-Wallis test and chi-square test. Survival curves were estimated using the Kaplan-Meier method and compared between groups by the log-rank test. All analyses were performed using SAS 9.3 software (SAS, Inc., Cary, NC) and SPSS Statistics 18 (SPSS, Inc., Chicago, IL), with p less than 0.05 considered to indicate significance.
Results
Of 565 patients who underwent lobectomy with lymph node dissection for cT1a-2b N0-1 M0 NSCLC, 77 with insufficient pathological data on the number and extent of nodal resections were excluded because they could not be classified into any group. The remaining 488 patients were included in the analysis. These subjects comprised 307 men and 188 women and had a median age of 69 years (range 38-85). According to our criteria, 145, 190, and 153 patients were classified into the L-SND, SND, and NS groups, respectively. The median follow-up after surgery was 66.5 months (range 1-97) and there was no significant difference in the follow-up period among the three groups (p ¼ 0.055).
Postoperative OS curves are shown in Figure 1 and the characteristics of each group are summarized in Table 1 . The 5-year OS rates were 74.7%, 73.8%, and 70.9% in the L-SND, SND, and NS groups, respectively, with no significant difference in postoperative survival among the groups (p ¼ 0.552). A significantly higher number of patients in the SND group had preoperative PET scans, large tumors, advanced cT and cN stage, lower lobectomy, and surgery by open thoracotomy than in the other groups. The rate of detection of pN2 was also significantly higher in the SND group, which might be due to the larger proportion of patients with advanced disease in this group.
To eliminate selection biases caused by such confounding factors, PS matching between the L-SND and SND groups was conducted and 49 cases in each group were finally matched. The patient characteristics after matching are shown in Table 2 . There were no significant differences in these characteristics, except for the number of resected lymph nodes. The rate of detection of pN2 also showed no significant difference between the groups (8.2% in each group). There was no case in the SND group with a metastasized lymph node in an area that would not have been treated if L-SND had been performed. Postoperative OS curves after PS matching are shown in Figure 2 and outcomes are given in Table 3 . The 5-year OS rates were 73.5% in the L-SND group and 75.3% in the SND group, with no significant difference between the groups (p ¼ 0.977) despite the SND group having a significant tendency to receive adjuvant chemotherapy (p ¼ 0.046). The rates of major complications and recurrence rates also did not differ significantly between the groups. A similar absence of a significant difference was found in subgroup analyses stratified by cT stage, cN stage, and lobar location of the primary tumor. Subgroup analysis stratified by histological type also showed no significant difference between the L-SND group and the SND group (Fig. 3) .
Discussion
Systematic lymph node dissection was first reported by Cahan in 1960 13 and is now a standard procedure in surgical treatment for NSCLC. This technique is designed to provide precise information on nodal status, which is necessary for optimal postoperative treatment and to achieve better local control that subsequently improves 18 Darling et al. 19 found no significant difference in postoperative recurrence and survival between systematic sampling, which is defined as removal of one or more lymph nodes guided by representative preoperative or intraoperative findings, and SND in a RCT in more than 1000 patients. There was also no difference in postoperative complications between the two groups. However, the study design included initial sampling of mediastinal and hilar lymph nodes and other suspicious lymph nodes, followed by randomization of only patients with negative nodal metastases verified by intraoperative frozensection examination into groups with all lymph nodes sampled (no further lymph node removal) and SND. However, only one to four additional lymph nodes from each station were removed after prerandomized lymph node sampling in the SND group, and the differences in the number of resected lymph nodes and surrounding fat tissue between the two groups were unclear. These factors may have contributed to the lack of differences in postoperative morbidity and mortality between the two Figure 2 . Postoperative overall survival in the L-SND and SND groups after propensity score matching. a Including ipsilateral lung metastasis, regional LN metastasis, and malignant effusion. PS, propensity score; L-SND, lobe-specific lymph node dissection; SND, systematic lymph node dissection; LN, lymph node.
groups. Moreover, mediastinal lymph node metastases were found to have been overlooked by systematic sampling in 4% of patients, and it was concluded that SND should be recommended for all patients with resectable NSCLC. 19 There have been no comparisons of L-SND with SND in a RCT and only a few comparisons in retrospective studies. Okada et al. performed L-SND for 377 patients with clinicosurgical stage I NSCLC and reported equivalence of the recurrence pattern, postoperative diseasefree survival (DFS), and OS with L-SND when compared with SND. The rate of patients with pN2 also showed no significant difference (0.5% in the L-SND group and 0.8% in the SND group), but postoperative morbidity was significantly lower in the L-SND group. 8 However, some biases may have been present because the SND group was a historical control group. Maniwa et al. 20 performed L-SND for 129 patients with NSCLC and found no significant difference in DFS and OS compared with those of the patients who underwent SND. The rate of pN2 cases was also approximately equal between the two groups. The L-SND group had a shorter operative time, but postoperative morbidity did not differ significantly between the groups. However, selection biases were present because L-SND was performed only for patients with operative risk factors or bronchioalveolar carcinoma. 20 To eliminate such biases, Ishiguro et al. 21 conducted a retrospective comparison of L-SND and SND using PS quartile-stratified Cox proportional hazard models in 147 patients who underwent L-SND. OS did not differ between the groups. Patients who underwent L-SND had a shorter operative time, a lower intraoperative blood loss, and a shorter hospital stay compared with those who underwent SND. However, the accuracy of nodal staging could not be evaluated because of the study design. 21 To avoid the limitations in previous studies, the current retrospective cohort study comparing L-SND to SND was performed using the PS matching method. The results showed no significant difference in postoperative OS between L-SND and SND after PS matching. This finding is consistent with previous reports, and we therefore believe that L-SND does not worsen postoperative OS compared with SND. Regarding nodal staging, we did not find a difference in the rate of detection of pN2 cases between L-SND and SND after PS matching, although the total number of resected lymph nodes was smaller in the L-SND group. This may be because metastases are rare in the lymph node area that is not dissected in L-SND, as was also found by Okada et al. 6 and Asamura et al. 7 Thus, L-SND may suffice for accurate nodal staging. Okada et al. 8 and Maniwa et al. 20 also showed equivalent rates of pN2 cases, and thus we believe that L-SND is not inferior to SND in accuracy of nodal staging. We also found no significant differences in operative time, intraoperative blood loss, and major complications between L-SND and SND. L-SND is a procedure in which some nodal stations are left untouched and unresected depending on the lobar location of the primary tumor, and this is the major difference compared with systematic sampling or SND. Therefore, L-SND is theoretically expected to reduce postoperative morbidity related to the anatomical area of resected lymph nodes, such as recurrent nerve paralysis after resection of station 2R or 5, and Okada et al. 8 actually showed significantly lower postoperative morbidity in L-SND compared to SND. However, in studies by Okada et al. 8 and Maniwa et al., 20 the most common complication after lymph node dissection for NSCLC was arrhythmia, with patients treated with SND tending to have arrhythmia more frequently than those who underwent L-SND. In contrast, major complications such as chylothorax and bronchopleural fistula occurred rarely and did not differ significantly between L-SND and SND. This may be the reason for the discrepancy between our results and those from previous studies, because we could not collect detailed data on postoperative complications, except on rare but critical events. In addition, our L-SND group after PS matching had a slightly larger population of patients with thoracotomy, and this might have affected our results for operative time and intraoperative blood loss, which did not differ between the groups. Confirmation of the lower invasiveness of L-SND requires detailed evaluation of these parameters in a larger cohort. The current study had several limitations, including the small sample size, especially after PS matching. Other studies have analyzed data from 150 to 300 patients treated with L-SND, whereas we initially evaluated 145 patients but only 49 remained after PS matching. This reduction is unavoidable with the PS matching method.
We were also unable to analyze postoperative complications in detail, as already mentioned, and we had no information on preoperative CT findings and postoperative pathological data on adenocarcinoma subtypes. Therefore, patients with low-grade malignant tumors such as adenocarcinoma in situ or minimally invasive adenocarcinoma, which often show pure ground grass opacity findings on CT and may have a good prognosis without any nodal dissection, 22 may have been included in the study. However, we excluded patients who underwent sublobar resection, which is often used for patients with adenocarcinoma in situ or minimally invasive adenocarcinoma, and it is therefore unlikely that there were many such patients in this study. However, we cannot be certain of the percentage of patients who had low-grade malignant tumors. In addition, we did not include histological type as a preoperative potential confounding factor during PS matching because we collected histological data only from postoperative pathological records. However, histological type has been shown to be a predictive factor for lymph node metastasis, 23 and preoperative histological type, if available, should be taken into account in the decision on use of L-SND. A study of differences among histological types is necessary to resolve this issue.
The major limitation in the study is the retrospective design, which prevents complete elimination of bias in selection of patients, even when the PS matching method is used. The only way to eliminate all confounding factors and confirm the noninferiority of L-SND to SND is to conduct a well-designed prospective RCT with consideration of differences of histological type and with exclusion of patients with pure ground grass opacity on their preoperative CT scans. Such an RCT is currently being planned in Japan (Dr. Saji, Department Chest Surgery, St. Marianna University School of Medicine, personal communication).
In conclusion, our results showed that L-SND is not inferior to SND in terms of accuracy of staging and postoperative prognosis. These findings suggest that L-SND has the potential to be a standard procedure in surgery for cT1a-2b N0-1 M0 NSCLC. This warrants performance of a prospective RCT, and such a trial will be conducted in the near future.
